HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International Cooperation on Alternative Test Methods

This article was originally published in The Rose Sheet

Executive Summary

Alternative method validation organizations from U.S., EU and Japan, together with Health Canada, adopt framework for International Cooperation on Alternative Test Methods, announces European Center for the Validation of Alternative Methods (ECVAM). Initiative is product of September 2007 meeting of the International Cooperation on Cosmetics Regulation, which covered a range of issues including nanotechnology and good manufacturing practices (1"The Rose Sheet" Oct. 15, 2007, p. 4). ICCR also "recognized the importance of replacing, reducing and refining (less pain and distress) animal testing." Framework allows participating organizations to coordinate in designing validation studies, conducting scientific peer reviews and finally developing harmonized recommendations, according to ECVAM, which is joined by U.S. counterpart - the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) - as well as the Japanese Center for the Validation of Alternative Methods and a Canadian government rep. Under adopted schema, one validation organization will act as lead, drafting recommendations based on liaisons with others; if all parties are in agreement, they will finalize and forward recommendation to their respective regulatory authorities

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel